ArticleFrontiers in surgery2025
Complete laparoscopic ileal augmentation cystoplasty with modified ureteral reimplantation using an extra peritoneal approach for neurogenic bladder with vesicoureteral reflux in patient: a case report.
Article in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Neurogenic bladder (NGB) is defined as bladder dysfunction. Patients with NGB often have issues with high-pressure storage of urine in the bladder and/or coordinated emptying of urine. Neurogenic bladders with high pressure may lead to vesicoureteral reflux (VUR).High-grade VUR leads to recurrent urinary tract infections (UTIs), and thus causes severe renal failure. Augmentation cystoplasty (AC) can reduce bladder pressure, increase bladder compliance, reduce vesicoureteral reflux, reduce the incidence of urinary incontinence, and improve the quality of life of patients. In recent years, with the maturity of laparoscopic technology, laparoscopic ileal augmentation cystoplasty has been widely used in clinical practice. However, through searching the database, we did not find any medical records of AC performed under complete laparoscopic via extraperitoneal approach. We report today a case of complete laparoscopic ileal augmentation cystoplasty with modified ureteral reimplantation using an extraperitoneal approach for neurogenic bladder with vesicoureteral reflux in a patient. Case presentation: A 61-year-old women was hospitalized with symptoms of recurrent frequent urination. The patient had a urine volume of about 50 ml each time, no symptoms of dysuria, and no previous history of tuberculosis, diabetes and lumbar disc herniation. After admission, in addition to routine examinations, we also conducted abdominal CT, retrograde cystography, cystoscopy and urodynamic examination for the patient. Eventually, the patient was diagnosed with neurogenic bladder and bilateral ureteral reflux. The patient underwent a complete laparoscopic ileal augmentation cystoplasty with modified ureteral reimplantation using an extraperitoneal approach. Six months after the operation, the bladder volume expanded to 400 ml, and acute pyelonephritis did not occur. We ordered a CT scan of the patient, which showed no dilated ureter. Conclusion: Complete laparoscopic ileal augmentation cystoplasty with modified ureteral reimplantation using an extraperitoneal approach is difcult due to the complex operation procedure and technical difculties. This investigation demonstrated that the extraperitoneal technique of enterocystoplasty that we describe is safe and feasible and has the advantages of less trauma, less bleeding, faster return of intestinal function, and fewer postoperative complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.